Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?
Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?
Cancer. 2010 Oct 26;
Authors: Tefferi A
PMID: 20979064 [PubMed - as supplied by publisher]
